Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Viridin

Abstract

VIRIDIN, an antibiotic produced by a pigment-forming strain of the common soil fungus Trichoderma viride, was first described by Brian and McGowan1, and Brian, Curtis, Hemming and McGowan2. Viridin is not anti-bacterial but is highly antifungal. Its activity against certain fungi is remarkably high. Germination of the spores of, for example, Botrytis allii is prevented by a concentration of 0.019 p.p.m. of α-viridin or 0.156 p.p.m. of β-viridin. Among synthetic fungicides, only the organo-mercurials are of the same order of activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Brian, P. W., and McGowan, J. C., Nature, 156, 144 (1945).

    Article  ADS  CAS  Google Scholar 

  2. Brian, P. W., Curtis, P. J., Hemming, H. G., and McGowan, J. C., Ann. App. Biol., 33, 190 (1946).

    Article  CAS  Google Scholar 

  3. Girard, A., and Sandulesco, G., Helv. Chem. Acta, 19, 1905 (1936).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

VISCHER, E., HOWLAND, S. & RAUDNITZ, H. Viridin. Nature 165, 528 (1950). https://doi.org/10.1038/165528a0

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/165528a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing